- Articles de Revue
- Published:
Spermatozoïdes, environnement et prévention
Spermatozoon, environment and prevention
Andrologie volume 4, pages 13–21 (1994)
Resume
Au cours des 50 dernières années, les facteurs de risque conduisant à l’infertilité ont nettement augmenté, surtout ceux liés à l’environnement. La spermatogénèse et les spermatozoïdes sont susceptibles d’être affectés par des agents physiques et chimiques, toxiques ou médicamenteux, mais aussi par des facteurs naturels comme le stress ou l’âge paternel. Ce dernier facteur et les précédents peuvent évidemment être intriqués. Leur ensemble aboutit à une baisse de la fertilité masculine et il est ainsi possible de définier des populations à risque.
Ces altérations de la spermatogénèse peuvent en outre entraîner des anomalies chez la progéniture tels qu’avortements précoces, chute du poids de naissance, syndromes autosomiques dominants aboutissant à des malformations ou à des troubles fonctionnels, en particulier comportementaux, troubles de la spermatogénèse analogues à ceux présentés par le pére, leucémies etc.
De telles données devraient conduire à un renforcement de la prévention et au dépistage de l’hypofertilité avent la trentaine.
Abstract
Over the last fivty years, the risk factors for infertility have increased substantially, particularly those due to the environment. Spermatogenesis and spermatozoa can be affected by physical (ionizing radiation microwaves, heat, cryopreservation) or chemical agents (antimitotics drugs, antibiotics, tranquillizers, insecticides, pesticides, industrial solvants, some heavy metals, alcohol, cannabis etc.). Some natural factors, as stress or paternal age (ageing or very youthful age relatively to about thirty) also seems to affect spermatogenesis and, particularly, the age can be joined with the previous ones. On the whole, these factors are able to decrease the male fertility through some changes about the concentration, the motility or the morphology of spermatozoa and so it is possible to describe populations subject to the risk.
Moreover, these spermatogenetic changes can lead abnormalities in progeny. For instance, some antimitotic drugs as cyclophosphamide, when administrated to the male rat, lead malformations or functional anomalies as behavioral troubles. The industrial solvents lead a decrease of the birth weight and the cannabis leads an increase of the ante-or post-natal death. Moreover, the change of the paternal spermatogenesis caused by cannabis can be found again in the male progeny. The problem is similar with the lead, the benzodiazepines and the alcohol.
Concerning the physical factors, some authors have shown that the children born from radiation exposed fathers presented an increase of the probability of leukemia. In animal, the postimplantation loss is increased when the father is irradiated or subjected to heat before mating.
Finally, the paternal ageing is responsible for new dominant autosomic mutations. Moreover, in animal and man, paternal ageing and, in man, very youthful age, also seems responsible for a gradual lowering in the level of progency cerebral functions.
On the whole, these data should lead to an preventive attitude which would be more effective before about thirty years of age than after this period.
Bibliographie
ABEL E.L.: Paternal Behavioral Mutagenesis. Neuro Toxicology, 1989, 10: 335–346.
ADAMS P.M., FABRICANT J.D., LEGATOR M.S.: Cyclophosphamide induced spermatogenetic effects detected in the F1 generation by behavioral testing. Science 1981, 211: 80–83.
ALI BH. Pharmacology and toxicity of furaroldone in man and animals: some recent research. Gén. Pharmacol. 1989, 20: 557–563.
ALVAREZ M.R.: Numerical chromsome variation in mouse spermatogonia resulting from alcohol consumption. J. Heredity, 1983, 74: 58–61.
ANDERSON B.A.: Male age and infertility. Result from Ireland prior to 1911. Pop. Index 1975, 41: 561–567.
ANDERSON R.A., WILLIS B.R., OSWALD C., ZANEVELD LJ.: Ethanol-induced male infertility: impairment of spermatozoa. J. Pharmacol. Exp. Therapeut., 1983, 225: 479–486.
ASCHWOOD-SMITH M.J.: The cryopreservation of human embryos. Hum. Reprod. 1986, 1: 319–322.
AUROUX M.: La physiotératogénèse du comportement. Un nouvel aspect de la pathologie du développement prénatal. J. Gyn. Obst. Biol. Repr. 1981, 10: 633–640.
AUROUX M.: Decrease of learning capacity in offspring with increasing paternal age in the rat. Teratology, 1983, 27: 141–148.
AUROUX M.: Age du père et développment. Contracept. Fertil. Sex. 1993, 21: 382–385.
AUROUX M., DULIOUST E., NAWAR N.N.Y., YACOUB S.G., KEMPF E.H., EBEL A.B.: Cyclophosphamide in the male Rat: cerebral biochemical changes in progeny. Biomed. Pharmacother. 1990, 44: 519–523.
AUROUX M, DULIOUST E., SELVA J., RINCE P.: Cyclophosphamide in the F0 male Rat: physical and behavioral changes in three successive adult generations. In: “Male mediated F1 abnormalities”. Mutat. Res. 1990, 229: 189–200.
AUROUX M., MAYAUX M.J., GUIHARD-MOSCATO M.L., FROMANTIN M., BARTHE J., SCHWARTZ D.: Paternal age and mental functions of progeny in man. Hum. Reprod. 1989, 4: 794–797.
BATTERSBY S., CHANDLER J.A., MORTON M.S.: Toxicity and uptake of heavy metals by human spermatozoa. Fertil. Steril. 1982 37: 230–235.
BOUQUET M., SELVA J., AROUX M.: Cryopreservation of Mouse Ovocytes: Mutagenic Effects in the Embryo? Biol. Reprod., 1993, 49: 764–769.
CARLSEN E., GIWERCMAN A., KEIDING N., SKAKKEBAEK NE.: Evidence for decreasing quality of semen during past 50 years. Brit. Med. J. 1992, Sept. 12, 305: 609–613.
DE COSTER R.: Endocrinological effect of single daily ketoconazole administration in male beagle dogs. Acta Endocrinol. 1989, 53: 203–205.
COX B.D., LYON M.F.: The induction by X-Rays of chromosome aberrations in germ cells of male guinea-pigs, golden hamsters and rabbits. I. Dose response in post-meiotic stages. Mutat. Res., 1975, 29: 93–109.
Czyglik F.: Autoconservation de sperme avant thérapeutique stérilisante: indications et résultats. In: L’insémination artificielle, CECOS ed. Masson, PARIS, 1991, 53–61.
DALTERIO S., DADR F., BARTKE A. and MAYFIELD D.: Cannabinoids in male mice: Effects on fertility and spermatogenesis. Science 1982, 216: 315–316.
DANIELL W.E., VAUGHAN T.L.: Paternal employment in solvent related occupations and adverse pregnancy outcomes. British J. Indust. Med. 1988, 45: 193–197.
DUBAR R.: Stress as a good contraceptive. New Scientist. 1985, 17: 16–18.
DWIVEDI C.: Cadmium induced sterility possible involvement of the cholinergic system. Arch. Environ. Contam. Toxicol. 1983, 12: 151–156.
ESCALIER D., BISSON J.P.: Quantitative ultrastructural modifications in human spermatozoa after freezing. In: David G., Price W. eds. Human artificial insemination and semen preservation. New York: Plenum Press, 1980, 107–122.
FERRADINI C., PUCHEAULT J.: Biologie de l’action des rayonnements ionisants. Paris. Masson 1983.
FIGA-TALAMANCA I., DELL’ORCO V., PUPI A., DONDERO F., GANDINI L., LENZI A., LOMBARDO F., SCAVALLI P., MANCINI G.: Fertility and semen quality of workers exposed to high temperatures in the ceramics industry. Reprod. Toxicol. 1992, 6: 517–523.
GARDNER M.J., SNEE P.M., HALL A.J., POWELL A.C., DOWNES S., TERRELL J.D. Results of case-control study of leukemia and lymphona among young people near Sellafied nuclear plant in West Cumbria. Brit. Med. J. 1990, 300: 423–429.
GILL W.B., SCHUMACHER G.F.B., BIBBO M.: Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylsilbestrol in utero. J. Urol. 1977, 117, 477–480.
GILL W.B., SCHUMACHER G.F.B., BIBBO M., STRAUS F.H., SHOENBERG H.W.: Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J. Urol. 1979, 122: 36–39.
HARDIN B.D.: Reproductive Toxicity of the glycol ethers. Toxicology 1983, 27: 91–102.
HILL C.R., CLARK P.R., GROWE M.R., HAMMICK J.E.: Biophysical effects of cavitation in a 1 MHz ultrasonic beam. Ultrasonics for industry 1969. Conference papers: 26–30.
HOLLAND M., WHITE I.G.: Heavy metals and spermatozoa. 1. Inhibition of the mobility and metabolism of spermatozoa by metals related to copper. Fertil. Steril. 1980, 34: 483–489.
JEGOU B., VELEZ de la CALLE J.F., BAUCHE F.: Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring. Proc. Natl. Acad. Sci. USA, 1991, 88: 8710–8714.
KITABATAKE T., WATWABE T., SATO T.: Sterility in japanese radiologicol technicians. Tahoku J. Exp. med., 1974, 42: 209–212.
LANCRANJAN I.: Alterations of spermatic liquid in patients chronically poisoned by carbon disulphide. Med. Lav. 1972, 63: 29–33.
LANCRANJAN I., MAIGANESCU M., RAFAILA E.: Gonadic function in workmen with long term exposure to microwaves. Health Phys. 1975, 29: 381–383.
LANCRANJAN I., POSPESCU H.I., KLEPSCH J.: Changes of the gonadic function in chronic carbon disulphide poisoning. Med. Lav. 1969, 60: 566–571.
LAUWERYS R., ROELS H., GENET P., TOUSSAIN G., BOUCKAERT A., DE COOMAN S.: Fertility of male workers exposed to mercury vapor or to managanese dust — a questionnaire study. Am. J. Ind. Med. 1985, 7: 171–176.
LEE I.P., DIXON R.L.: Effects of mercury on mouse spermatogenesis studied by cell separation and serial mating. Toxicol. Appl. Pharmacol. 1973, 25: 464.
LEIBOVITZ B., SIEGEL B.V.: Aspect of free radical reactions in biological systems. Aging J. Gerontol 1980, 35: 45–56.
MEISTRICH M.L., SAMUELS R.C.: Reduction in sperm levels after testicular irradiation of the mouse: a comparison with man. Radiat. Res., 1985, 102: 138–147.
MIEUSSET R.: Effects de la température sur les fonctions testiculaires et épididymaires. Thèse 3è cycle Biologie de la Reproduction, Université de Paris XI, CHU Bicêtre, 1992.
NOMURA T.: Parental exposure to X-rays and chemicals induces heritable tumours and anomalies in mice. Nature, 1982, 296: 575–577.
POPESCU H.I., LANCRANJAN I.: Spermatogenesis alteration during protected irradiation in man. Health Phys., 1975, 28: 567–573.
RAO B., DAVID G.: Improved recovery of posttham motility and vitality of human spermatozoa cryopreserved in the presence of dithiothreitol. Cryobiology 1984, 21, 536–541.
RATCLIFFE J.M., SCHRADER S.M., STEENLAND K., CLAPP D.E., TRNER T., HORNUNG R.W. Semen quality in papaya workers with long term exposure to ethylene dibromide. Brit. J. Indust. Med., 1987, 44: 317–326.
ROYERE D., HAMAMAH S., NICOLLE J.C., BARTHELEMY C., POINDRON J., ROUSSIE M., LANSAC J.: Effects de la congélation sur la stabilité de la chromatine des spermatozoïdes humains: étude cytophotométrique. Fertil. Contracep. Sexual 1987, 15: 718–721.
SERRES C., JOUANNET P., CZYGLIK F., DAVID G.: Effects of freezing on spermatozoa motility. In: David G., Price W. eds. Human artificial insemination and semen preservation. New York: Plenum Press, 1980, 147–160.
SSCHRODER J.H., HUG O.: Dominante letal mutationen in der nachkommenschaft bestrahlter mänulicher mäuse. Mutat. Res. 1971, 11: 215–245.
SCHWARTZ D., MAYUX M.J., SPIRA A., MOSCATO ML., JOUANNET P., CZYGLIK F., DAVID G.: Semen characteristics as a function of age in 833 fertile men. Fertil. Steril. 1983, 39: 530–535.
SPIRA A., DUCOT B., JOUANNET P., SOUMAH A., FENEUX D., ALBERT M: Consommation de tabac, d’alcool et fertilité masculine. In: Facteurs de la stérilité humaine, A. SPIRA et P. JOUANNET Eds. INSERM 1981, Vol. 103: 363–372.
STANWELL-SMITH R., THOMPSON S.G., HAINES A.P., WARD RJ., CASHMORE G., STEDRONSKA J., HENDRY WF.: A comparative study of zinc, copper, cadnium and lead levels in fertile and infertile men. Fertil. Steril. 1983, 40: 670–677.
STEENO O.P., PANGKAHILA A.: Occupational influences on male fertility and sexuality. Androl., 1983, 16: 5–22.
TOTH A.: Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil. Steril. 1979, 31: 538–540.
TRASLER J.M., HALES B.F., ROBAIRE B.: Paternal cyclophosphamide treatment of rats causes foetal loss and malformations without affecting male fertility. Nature 1985, 316: 144–146.
VAN THIEL D.H., GAVALER J.S., COBB C.F., SHERINS RJ., LESTER R.: Alcohol induced testicular atrophy in the adult made rat. Endocrinology, 1979, 105: 888–895.
VELEZ de la CALLE JF., JEGOU B.: Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats. Cancer Res., 1990, 50: 1308–15.
VELEZ de la CALLE JF., SOUFIR JC., CHODORGE F., BOISSEAU C., KERCRET H., JEGOU B.: Reproductive effects of anti-cancer drug procarbazine in male rats at differents ages. J. Reprod. Fertil., 1988, 84: 51–61.
WAR R.N. and DAS R.K.: Induction of sperm head abnormalities in mice by three tranquillizers. Cytobios 1983, 36: 45–51.
WYBOREK A.J. and BRUCE W.R.: The induction of sperm-shape abnormalities in mice and humans. In CHEMICAL MUTAGENS, Vol. 5, A. Hollaender and F.J. de Serres eds. Plenum Pub. Corp. NEW-YORK 1978, 257–285.
WYBOREK A.J., GORDON L.A., BURKHART J.G., FRANCIS MW., KAPP RW., LETZ G., MALLING HV., TOPHAM JC., WHORTON MD.: An evaluation of the mouse sperm morphology test and other sperm tests in non human mammals. Mutat. Res. 1983, 115: 1–72.
WYBOREK A.J., GORDON L.A., BURKHART J.G., FRANCIS MW., KAPP RW. Jr, LETZ G., MALLING HV., TOPHAM JC., WHORTON MD.: An evaluation of human sperm as indicators of chemically induced alteration of spermatogenic function. Mutat. Res. 1983, 115: 73–148.
YU-HU L., ZHI-QIANG L., YAO-QUN W., HUAN BING L., BING-REN F.: Long term effect on human spermatogenesis after microwaves treatment of testes. J. Bioelectricity, 1988, 7: 97–102.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Auroux, M., Dulioust, E. & Fendeux, D. Spermatozoïdes, environnement et prévention. Androl. 4, 13–21 (1994). https://doi.org/10.1007/BF03034615
Issue Date:
DOI: https://doi.org/10.1007/BF03034615